Cytotoxicity and Genotoxicity in Human Embryonic Kidney Cells Exposed to Surface Modify Chitosan Nanoparticles Loaded with Curcumin

AAPS PharmSciTech

Volumn 17, Issue 6, 2016, Pages 1347-1352

  Zheng, Yu ^a,b   Chen, Yan ^b   Jin, Ling Wei ^b   Ye, Han Yang ^b   Liu, Gang ^a  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

chitosan nanoparticles; cytotoxicity; genotoxicity; HEK 293 cells; phosphatidylserine

Indexed keywords

CHITOSAN NANOPARTICLE; CURCUMIN; CYCLOPHOSPHAMIDE; PHOSPHATIDYLSERINE; CHITOSAN; CYTOTOXIN; DRUG CARRIER; MUTAGENIC AGENT; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEDIATED CYTOTOXICITY; CELL VIABILITY; CONTROLLED STUDY; DISPERSITY; GENOTOXICITY; HEK293 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MORPHOLOGICAL TRAIT; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; PROCEDURES; RAT;

ANIMALS; CELL LINE; CELL SURVIVAL; CHITOSAN; CURCUMIN; CYTOTOXINS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HEK293 CELLS; HUMANS; MICE; MICE, INBRED BALB C; MUTAGENS; NANOPARTICLES; PARTICLE SIZE; RATS;

EID: 84952641872     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-015-0471-1     Document Type: Article

References (22)

1. Wang Q. Nanoparticles for applications in drug delivery.
2. Dwivedi P, Kansal S, Sharma M, Shukla R, Verma A, Shukla P, et al. Exploiting 4-sulphate N-acetyl galactosamine decorated gelatin nanoparticles for effective targeting to professional phagocytes in vitro and in vivo. J Drug Target. 2012;20(10):883–96.
3. Vorup-Jensen T, Peer D. Nanotoxicity and the importance of being earnest. Adv Drug Deliv Rev. 2012;64(15):1661–2.
4. Donaldson K, Poland CA. Nanotoxicity: challenging the myth of nano-specific toxicity. Curr Opin Biotechnol. 2013;24(4):724–34.
5. Tiyaboonchai W. Chitosan nanoparticles: a promising system for drug delivery. Naresuan Univ J: Scie Technol. 2013;11(3):51–66.
6. Khatik R, Mishra R, Verma A, Dwivedi P, Kumar V, Gupta V, et al. Colon-specific delivery of curcumin by exploiting Eudragit-decorated chitosan nanoparticles in vitro and in vivo. J Nanoparticle Res. 2013;15(9):1–15.
7. Riva R, Ragelle H, des Rieux A, Duhem N, Jérôme C, Préat V. Chitosan and chitosan derivatives in drug delivery and tissue engineering. Chitosan for biomaterials II: Springer; 2011. p. 19-44.
8. Gupta SC, Patchva S, Koh W, Aggarwal BB. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 2012;39(3):283–99.
9. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013;15(1):195–218.
10. Khatik R, Dwivedi P, Shukla A, Srivastava P, Rath SK, Paliwal SK, et al. Development, characterization and toxicological evaluations of phospholipids complexes of curcumin for effective drug delivery in cancer chemotherapy. Drug Deliv. 2014:1–12.
11. Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 1998;5(7):551–62.
12. Kansal S, Tandon R, Dwivedi P, Misra P, Verma PR, Dube A, et al. Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis. J Antimicrob Chemother. 2012;67(11):2650–60.
13. Khatik R, Dwivedi P, Junnuthula VR, Sharma K, Chuttani K, Mishra AK, et al. Potential in vitro and in vivo colon specific anticancer activity in a HCT-116 xenograft nude mice model: targeted delivery using enteric coated folate modified nanoparticles. RSC Adv. 2015;5(21):16507–20. doi:10.1039/C4RA15114C.
14. More AB, Chilgunde SN, Kamble JC, Patil PS, Malshe VC, Vanage GR, et al. Polyethylene sebacate: genotoxicity, mutagenicity evaluation and application in periodontal drug delivery system. J Pharm Sci. 2009;98(12):4781–95.
15. Love SA, Maurer-Jones MA, Thompson JW, Lin Y-S, Haynes CL. Assessing nanoparticle toxicity. Annu Rev Anal Chem. 2012;5:181–205.
16. Chaudhury A, Das S. Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents. AAPS PharmSciTech. 2011;12(1):10–20.
17. Anitha A, Deepagan V, Rani VD, Menon D, Nair S, Jayakumar R. Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles. Carbohydr Polym. 2011;84(3):1158–64.
18. Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer. 2011;10(12):1–19.
19. Zhou H, Beevers CS, Huang S. Targets of curcumin. Curr Drug Targets. 2011;12(3):332.
20. He M, Kubo H, Morimoto K, Fujino N, Suzuki T, Takahasi T, et al. Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells. EMBO Rep. 2011;12(4):358–64.
21. Rao KS, Xu Y, Shaw E, Parton JW. Mutagenicity testing applied for regulation of developing products. Curr Sep. 2004;20:141–4.
22. Putman DL, Clarke JJ, Escobar P, Gudi R, Krsmanovic LS, Pant K, et al. Toxicological testing handbook principles, applications, and data interpretation. In: Jacobson-Kram D, Keller KA, editors. Genetic toxicology. New York: Informa Healthcare USA, Inc; 2006.